Overexpression of IL-1β in the 3xTg-AD mouse model, however, promotes opposing effects on the amyloid and tau pathologies by accelerating the accumulation of pathological forms of tau while reducing the overall levels of Aβ plaques. Here, IL1B is linked to Alzheimer disease.